MMI to Present at the 41st Annual J.P. Morgan Healthcare Conference
By Business Wire
JACKSONVILLE, Fla.--(BUSINESS WIRE)--MMI (Medical Microinstruments, Inc.), a robotics company dedicated to improving clinical outcomes for patients undergoing microsurgery, today announced that it will participate in the 41st Annual J.P. Morgan Healthcare Conference taking place in San Francisco, California on January 9-12, 2023.
Mark Toland, Chief Executive Officer, is scheduled to present on Tuesday, January 10, 2023, at 11:30 a.m. PST / 8:30 a.m. EST at the Westin St. Francis Hotel in the Mission Bay Meeting Room. A Q&A session will follow the presentation.
MMI (Medical Microinstruments, Inc.) was founded in 2015 near Pisa, Italy to enhance surgical performance through the development of a robotic system that enables surgeons to achieve better outcomes in microsurgery. The Symani Surgical System combines proprietary innovations including the world’s smallest wristed microinstruments as well as tremor-reducing and motion-scaling technologies. Together, these powerful capabilities allow more surgeons to successfully perform microsurgery while expanding the field of supermicrosurgery. The Symani System is CE Marked and commercially available in Europe. In the United States, the system is currently under development and remains investigational. MMI is backed by international medtech investors including Andera Partners, BioStar, Deerfield Management, Fountain Healthcare Partners, Panakès Partners, RA Capital and Sambatech.Contacts TechDogs homepage to find the latest tech content infused with drama and entertainment. We've got Articles, White Papers, Case Studies, Reports, Videos and Events – the complete lot to help you Know Your World of Technology.
First published on Wed, Jan 4, 2023
Disclaimer - Reference to any specific product, software or entity does not constitute an endorsement or recommendation by TechDogs nor should any data or content published be relied upon. The views expressed by TechDogs’ members and guests are their own and their appearance on our site does not imply an endorsement of them or any entity they represent. Views and opinions expressed by TechDogs’ Authors are those of the Authors and do not necessarily reflect the view of TechDogs or any of its officials. All information / content found on TechDogs’ site may not necessarily be reviewed by individuals with the expertise to validate its completeness, accuracy and reliability.
Join The Discussion